The RUNX1-RUNX1T1 fusion gene, resulting from t(8;21) translocation, is characteristic of AML with favorable outcomes, affecting myeloid differentiation and response to treatment [6,7]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.